Item 8.01. Other Events.
As previously reported on a Current Report on Form 8-K filed on February 14,
2022 with the U.S. Securities and Exchange Commission (the "SEC") by Modular
Medical, Inc. (the "Company"), on February 9, 2022 (the "Effective Date"), the
Company entered into an underwriting agreement with Oppenheimer & Co. Inc.
("Oppco") whereby the Company agreed to enter into a "lock-up" agreement (the
"Lock-Up"), pursuant to which the Company agreed not to offer for sale, issue,
sell, contract to sell, pledge or otherwise dispose of any of its shares of
common stock or securities convertible into common stock for a period of 180
days after the Effective Date (the "Lock-Up Period").
On March 28, 2022, Oppco provided the Company with a waiver to the Lock-Up (the
"Waiver") to allow the Company to file a registration statement on Form S-3 with
the SEC to effect the shelf registration of an indeterminate amount of the
Company's equity, equity-linked and/or debt securities (the "Shelf Registration
Statement") prior to the expiration of the Lock-Up Period.
The Waiver is limited to the filing of the Shelf Registration Statement, and, if
the Company intends to file a prospectus supplement to the Shelf Registration
Statement and/or to make any sales pursuant to the Shelf Registration Statement
prior to the expiration of the Lock-Up Period, the Company must obtain Oppco's
written consent before doing so.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
Exhibit No. Description
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses
MODULAR MEDICAL, INC. 
